$ACTG
ACACIA RESEARCH CORP Stock $actg

$actg Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000093454922000027 Filed on May 12, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$13.51M	$5.803M
YoY Change	132.76%	51.91%
Cost Of Revenue	$8.946M	$95.00K
YoY Change	9316.84%	-77.91%
Gross Profit	$4.561M	$5.708M
YoY Change	-20.09%	68.38%
Gross Profit Margin	33.77%	98.36%
Selling, General & Admin	$13.07M	$6.200M
YoY Change	110.79%	21.33%
% of Gross Profit	286.54%	108.62%
Research & Development	$190.0K	$0.00
YoY Change
% of Gross Profit	4.17%	0.0%
Depreciation & Amortization	$3.369M	$1.897M
YoY Change	77.6%	72.45%
% of Gross Profit	73.87%	33.23%
Operating Expenses	$13.26M	$6.200M
YoY Change	113.85%	4.91%
Operating Profit	-$8.508M	-$5.676M
YoY Change	49.89%	125.24%
Interest Expense	-$79.64M	-$158.0M
YoY Change	-49.61%	1644.28%
% of Operating Profit
Other Income/Expense, Net	-$79.64M	-$157.9M
YoY Change	-49.56%
Pretax Income	-$88.14M	-$163.6M
YoY Change	-46.11%	1194.97%
Income Tax	-$14.88M	$10.00K
% Of Pretax Income
Net Earnings	-$73.27M	-$164.5M
YoY Change	-55.45%	1356.73%
Net Earnings / Revenue	-542.43%	-2834.14%
Basic Earnings Per Share	-$1.61	-$2.81
Diluted Earnings Per Share	-$1.61	-$2.81
COMMON SHARES
Basic Shares Outstanding	46.54M shares	48.60M shares
Diluted Shares Outstanding	46.54M shares	48.60M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$572.6M	$475.7M
YoY Change	20.36%	200.91%
Cash & Equivalents	$289.4M	$180.2M
Short-Term Investments	$283.2M	$330.9M
Other Short-Term Assets	$4.961M	$2.647M
YoY Change	87.42%	-28.46%
Inventory	$10.01M
Prepaid Expenses
Receivables	$9.141M	$4.425M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$596.7M	$482.8M
YoY Change	23.59%	197.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.885M	$845.0K
YoY Change	359.76%	-39.64%
Goodwill	$7.470M
YoY Change
Intangibles	$45.76M
YoY Change
Long-Term Investments	$30.93M
YoY Change
Other Assets	$5.273M	$774.0K
YoY Change	581.27%	-97.85%
Total Long-Term Assets	$64.72M	$82.09M
YoY Change	-21.16%	60.02%
TOTAL ASSETS
Total Short-Term Assets	$596.7M	$482.8M
Total Long-Term Assets	$64.72M	$82.09M
Total Assets	$661.4M	$564.9M
YoY Change	17.09%	164.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.298M	$3.633M
YoY Change	45.83%	17.19%
Accrued Expenses	$16.20M	$15.69M
YoY Change	3.26%	1326.36%
Deferred Revenue	$1.453M
YoY Change
Short-Term Debt	$168.7M	$116.2M
YoY Change	45.13%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$194.4M	$138.0M
YoY Change	40.9%	1189.52%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.165M	$291.1M
YoY Change	-99.6%	795.55%
Total Long-Term Liabilities	$1.165M	$291.1M
YoY Change	-99.6%	795.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$194.4M	$138.0M
Total Long-Term Liabilities	$1.165M	$291.1M
Total Liabilities	$300.1M	$441.0M
YoY Change	-31.95%	879.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$255.0M	-$495.4M
YoY Change	-48.53%
Common Stock	$47.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$58.27M
YoY Change
Treasury Stock Shares	7.730M shares
Shareholders Equity	$334.4M	$128.0M
YoY Change
Total Liabilities & Shareholders Equity	$661.4M	$569.0M
YoY Change	16.25%	166.24%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$73.27M	-$164.5M
YoY Change	-55.45%	1356.73%
Depreciation, Depletion And Amortization	$3.369M	$1.897M
YoY Change	77.6%	72.45%
Cash From Operating Activities	-$3.163M	-$6.120M
YoY Change	-48.32%	178.18%
INVESTING ACTIVITIES
Capital Expenditures	$34.00K	$33.00K
YoY Change	3.03%	-100.56%
Acquisitions
YoY Change
Other Investing Activities	$9.965M	-$2.907M
YoY Change	-442.79%	-144.72%
Cash From Investing Activities	$9.931M	-$13.94M
YoY Change	-171.24%	-2888.0%
FINANCING ACTIVITIES
Cash Dividend Paid	$700.0K	$260.0K
YoY Change	169.23%
Common Stock Issuance & Retirement, Net	$10.99M	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$26.76M	-$260.0K
YoY Change	10192.31%	-108.67%
NET CHANGE
Cash From Operating Activities	-$3.163M	-$6.120M
Cash From Investing Activities	$9.931M	-$13.94M
Cash From Financing Activities	-$26.76M	-$260.0K
Net Change In Cash	-$19.99M	-$20.32M
YoY Change	-1.61%	-1663.08%
FREE CASH FLOW
Cash From Operating Activities	-$3.163M	-$6.120M
Capital Expenditures	$34.00K	$33.00K
Free Cash Flow	-$3.197M	-$6.153M
YoY Change	-48.04%	-266.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000934549
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	1-37721
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	Acacia Research Corporation
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	6th Floor
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4405754
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	767 Third Avenue,
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York,
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10017
CY2022Q1	dei	City Area Code CityAreaCode	949
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	480-8300
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2022Q1	dei	Trading Symbol TradingSymbol	ACTG
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45809745	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	289369000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	308943000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	246484000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	361778000	USD
CY2022Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	USD
CY2021Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	USD
CY2022Q1	actg	Equity Method Investments Current EquityMethodInvestmentsCurrent	30934000	USD
CY2021Q4	actg	Equity Method Investments Current EquityMethodInvestmentsCurrent	30934000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9141000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9517000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	10014000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	8930000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4961000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4764000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	596719000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	730682000	USD
CY2022Q1	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	0	USD
CY2021Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	418000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3885000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4183000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	7470000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	7470000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45759000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	48793000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2334000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2027000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5273000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5283000	USD
CY2022Q1	us-gaap	Assets Assets	661440000	USD
CY2021Q4	us-gaap	Assets Assets	798856000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5298000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5440000	USD
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	7349000	USD
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	6227000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4345000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3698000	USD
CY2022Q1	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	2303000	USD
CY2021Q4	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	2463000	USD
CY2022Q1	actg	Accrued Patent Investment Costs Current AccruedPatentInvestmentCostsCurrent	5000000	USD
CY2021Q4	actg	Accrued Patent Investment Costs Current AccruedPatentInvestmentCostsCurrent	0	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1453000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1114000	USD
CY2022Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	168661000	USD
CY2021Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	181248000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	194409000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	200190000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	660000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	581000	USD
CY2022Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	10395000	USD
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	11291000	USD
CY2022Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	14506000	USD
CY2021Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	18448000	USD
CY2022Q1	actg	Embedded Derivative Fair Value Of Embedded Derivative Liability1 EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability1	73118000	USD
CY2021Q4	actg	Embedded Derivative Fair Value Of Embedded Derivative Liability1 EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability1	96378000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2298000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2027000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3513000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18552000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1165000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6161000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	300064000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	353628000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	15904000	USD
CY2021Q4	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	14753000	USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46754930	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46754930	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48807748	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48807748	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	47000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	49000	USD
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	7730184	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5388469	shares
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	58267000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	47281000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	647640000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	648389000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-254990000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-181724000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	334430000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	419433000	USD
CY2022Q1	us-gaap	Minority Interest MinorityInterest	11042000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	11042000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	345472000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	430475000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	661440000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	798856000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13507000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5803000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	190000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2016000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	0	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11053000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6166000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	22015000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	11479000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8508000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5676000	USD
CY2022Q1	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	-172203000	USD
CY2021Q1	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	37849000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	66876000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	819000	USD
CY2022Q1	actg	Earnings On Equity Investment In Joint Venture EarningsOnEquityInvestmentInJointVenture	0	USD
CY2021Q1	actg	Earnings On Equity Investment In Joint Venture EarningsOnEquityInvestmentInJointVenture	2730000	USD
CY2022Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-105327000	USD
CY2021Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	41398000	USD
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2021Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2752000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	3591000	USD
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	28098000	USD
CY2021Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-198909000	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-813000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-24000	USD
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2601000	USD
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1157000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1007000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-26000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-79636000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-157879000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-88144000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-163555000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-14878000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-73266000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-163565000	USD
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	900000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-73266000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-164465000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-75117000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-75117000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-136512000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-136512000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46544313	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	46544313	shares
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	48596040	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48596040	shares
CY2021Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	260000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	450000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.61
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.61
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.81
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.81
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	430475000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-73266000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	1151000	USD
CY2022Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	700000	USD
CY2022Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	18770	shares
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	72000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1174000	USD
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	10988000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	345472000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	288316000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-163565000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	853000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	124088000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-73266000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-163565000	USD
CY2022Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	0	USD
CY2021Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-2752000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	3591000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3369000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1897000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	51000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	549000	USD
CY2022Q1	actg	Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative	3942000	USD
CY2021Q1	actg	Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative	-13691000	USD
CY2022Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	896000	USD
CY2021Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-11603000	USD
CY2022Q1	actg	Unrealized Gain Loss On Derivatives1 UnrealizedGainLossOnDerivatives1	23260000	USD
CY2021Q1	actg	Unrealized Gain Loss On Derivatives1 UnrealizedGainLossOnDerivatives1	-173615000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1174000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	450000	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-813000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-24000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-172203000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	37849000	USD
CY2022Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	66876000	USD
CY2021Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	819000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	0	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	2730000	USD
CY2022Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-15039000	USD
CY2021Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-318000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3919000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1084000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1246000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	843000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4261000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2332000	USD
CY2022Q1	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	-161000	USD
CY2021Q1	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	283000	USD
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	418000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3163000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6120000	USD
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2021Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	11000000	USD
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	3591000	USD
CY2022Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	92877000	USD
CY2021Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	9200000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	102842000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	2702000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9931000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13940000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10988000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	50000000	USD
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	15000000	USD
CY2021Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	50000000	USD
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	700000	USD
CY2021Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	260000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	72000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26760000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-260000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-19992000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-20320000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	309361000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	200546000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	289369000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180226000	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	10000	USD
CY2022Q1	actg	Patent Acquisition In Exchange Of Notes Receivable PatentAcquisitionInExchangeOfNotesReceivable	0	USD
CY2021Q1	actg	Patent Acquisition In Exchange Of Notes Receivable PatentAcquisitionInExchangeOfNotesReceivable	4000000	USD
CY2022Q1	actg	Patent Acquisition Accrued Liability Long Term PatentAcquisitionAccruedLiabilityLongTerm	0	USD
CY2021Q1	actg	Patent Acquisition Accrued Liability Long Term PatentAcquisitionAccruedLiabilityLongTerm	15000000	USD
CY2022Q1	actg	Number Of Patent Portfolios Acquired NumberOfPatentPortfoliosAcquired	0	patent
CY2021Q1	actg	Number Of Patent Portfolios Acquired NumberOfPatentPortfoliosAcquired	1	patent
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, estimates of variable consideration for revenue, including sales returns, the valuation of equity securities without readily determinable fair value, the determination of excess and obsolete inventories, bad debt allowances and product warranty liabilities, the valuation of Series A redeemable convertible preferred stock (the “Series A Redeemable Convertible Preferred Stock”), embedded derivatives, Series A warrants (the “Series A Warrants”) and Series B warrants (the “Series B Warrants”), stock-based compensation expense, impairment of goodwill, patent-related and other intangible assets, the determination of the economic useful life of amortizable intangible assets, and income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</span></div>
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	850000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	854000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P2Y
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	294740000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	48793000	USD
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	222000	USD
CY2022Q1	us-gaap	Product Warranty Expense ProductWarrantyExpense	11000	USD
CY2022Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	63000	USD
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	170000	USD
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents and accounts receivable. Acacia places its cash equivalents primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Six licensees individually accounted for more than 10% of total recognized revenue, ranging from 11% to 18%, during the three months ended March 31, 2022. Two licensees individually accounted for 61% and 9% of revenues recognized during the three months ended March 31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, Acacia has not had material foreign operations. Based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable license revenue arrangement, for the three months ended March 31, 2022 and 2021, 20% and 10%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. Refer to Note 15 for additional information regarding revenue from customers by geographic region.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three licensees individually represented approximately 44%, 44% and 12% of accounts receivable at March 31, 2022. Two licensees individually represented approximately 59% and 41% of accounts receivable at December 31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Industrial Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single Printronix customer accounted for more than 10% of revenue for the three months ended March 31, 2022. Printronix has significant foreign operations. Refer to Note 15 for additional information regarding net sales to customers by geographic region. Accounts receivable from one customer represented 13% of accounts receivable as of March 31, 2022, and one customer represented 11% of accounts receivable as of December 31, 2021. Exposure to credit risk is limited by the large number of customers comprising the remainder of the Printronix customer base and by periodic customer credit evaluations performed by Printronix.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single Printronix vendor accounted for 10% or more of purchases for the three months ended March 31, 2022. Accounts payable to one vendor represented 11% of accounts payable as of March 31, 2022, and one vendor represented 14% of accounts payable as of December 31, 2021.</span></div>
CY2022Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021Q4	us-gaap	Goodwill Goodwill	7470000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	156768000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	104075000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	14359000	USD
CY2022Q1	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	246484000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	99859000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	264879000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	2960000	USD
CY2021Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	361778000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1900000	USD
CY2022Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2022Q1	us-gaap	Goodwill Goodwill	7470000	USD
CY2022Q1	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	Embedded DerivativesEmbedded derivatives that are required to be bifurcated from their host contract are valued separately from the host instrument. A binomial lattice framework is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible Preferred Stock issued by the Company in 2019.
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.17
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	887000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	887000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	887000	USD
CY2021Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	4000000	USD
CY2022Q1	us-gaap	Interest Income Other InterestIncomeOther	78000	USD
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	3408000	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	3207000	USD
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1588000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1712000	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5453000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4011000	USD
CY2022Q1	us-gaap	Inventory Gross InventoryGross	10449000	USD
CY2021Q4	us-gaap	Inventory Gross InventoryGross	8930000	USD
CY2022Q1	us-gaap	Inventory Adjustments InventoryAdjustments	435000	USD
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	0	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	343533000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	297774000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	10014000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	8930000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4789000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4761000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	904000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	578000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3885000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4183000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	335000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	35000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45759000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	343533000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3000000	USD
CY2021Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021Q1	actg	Accelerated Amortization Of Patents AcceleratedAmortizationOfPatents	0	USD
CY2022Q1	actg	Accelerated Amortization Of Patents AcceleratedAmortizationOfPatents	0	USD
CY2022Q1	actg	Finite Lived Intangible Assets Write Offs FiniteLivedIntangibleAssetsWriteOffs	35000000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	9102000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	12068000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	10692000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	8348000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2483000	USD
CY2022Q1	actg	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	3066000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45759000	USD
CY2021Q4	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	5000000	USD
CY2022Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	78000	USD
CY2022Q1	actg	Accrued Consulting And Other Professional Fees AccruedConsultingAndOtherProfessionalFees	1335000	USD
CY2021Q4	actg	Accrued Consulting And Other Professional Fees AccruedConsultingAndOtherProfessionalFees	438000	USD
CY2022Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	3000000	USD
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	3000000	USD
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	493000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	506000	USD
CY2022Q1	actg	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	67000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3504000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1206000	USD
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	84000	USD
CY2022Q1	actg	Service Contract Costs Accrued Current ServiceContractCostsAccruedCurrent	269000	USD
CY2021Q4	actg	Service Contract Costs Accrued Current ServiceContractCostsAccruedCurrent	307000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1206000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	935000	USD
CY2022Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	968000	USD
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	957000	USD
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	7349000	USD
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	6227000	USD
CY2021Q1	actg	Debt Instrument Required Minimum Amount Held In Escrow DebtInstrumentRequiredMinimumAmountHeldInEscrow	35000000	USD
CY2021Q4	actg	Debt Instrument Required Minimum Amount Held In Escrow DebtInstrumentRequiredMinimumAmountHeldInEscrow	35000000	USD
CY2021Q4	actg	Number Of Board Of Directors NumberOfBoardOfDirectors	6	director
CY2022Q1	actg	Number Of Board Of Directors NumberOfBoardOfDirectors	7	director
CY2022Q1	actg	Number Of Additional Directors NumberOfAdditionalDirectors	2	director
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2298000	USD
CY2021	actg	Net Income For Settlement Offset By Contingency Accruals NetIncomeForSettlementOffsetByContingencyAccruals	1200000	USD
CY2022Q1	actg	Net Income For Settlement Offset By Contingency Accruals NetIncomeForSettlementOffsetByContingencyAccruals	0	USD
CY2021Q1	actg	Net Income For Settlement Offset By Contingency Accruals NetIncomeForSettlementOffsetByContingencyAccruals	0	USD
CY2022Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD
CY2021Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD
CY2022Q1	us-gaap	Legal Fees LegalFees	36000	USD
CY2021Q4	us-gaap	Legal Fees LegalFees	408000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	293000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	150000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	886000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1203000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	763000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	347000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	238000	USD
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	3125819	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y6M
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P1Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2022Q1	actg	Ownership Percent Of Voting Stock OwnershipPercentOfVotingStock	0.10
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	1080000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	8800000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P5Y
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-73266000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-164465000	USD
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	700000	USD
CY2021Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	263000	USD
CY2022Q1	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	1151000	USD
CY2021Q1	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	852000	USD
CY2022Q1	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic	0	USD
CY2021Q1	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic	-29068000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-75117000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-136512000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46544313	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46544313	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48596040	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48596040	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.61
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.61
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.81
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.81
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	109029318	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	107100391	shares
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8508000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-79636000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-88144000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6200000	USD
CY2022Q1	actg	Trading Securities Fair Value Disclosure TradingSecuritiesFairValueDisclosure	246484000	USD
CY2021Q4	actg	Trading Securities Fair Value Disclosure TradingSecuritiesFairValueDisclosure	361778000	USD
CY2022Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	USD
CY2021Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	30934000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	30934000	USD
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	283234000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	398528000	USD
CY2022Q1	us-gaap	Other Assets OtherAssets	152283000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	172726000	USD
CY2022Q1	us-gaap	Assets Assets	661440000	USD
CY2021Q4	us-gaap	Assets Assets	798856000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13507000	USD
CY2022Q1	us-gaap	Noncurrent Assets NoncurrentAssets	3885000	USD
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4183000	USD

Files In Submission

Name	View Source	Status
0000934549-22-000027-index-headers.html	Edgar Link	pending
0000934549-22-000027-index.html	Edgar Link	pending
0000934549-22-000027.txt	Edgar Link	pending
0000934549-22-000027-xbrl.zip	Edgar Link	pending
actg-20220331.htm	Edgar Link	pending
actg-20220331.xsd	Edgar Link	pending
actg-20220331_cal.xml	Edgar Link	unprocessable
actg-20220331_def.xml	Edgar Link	unprocessable
actg-20220331_htm.xml	Edgar Link	completed
actg-20220331_lab.xml	Edgar Link	unprocessable
actg-20220331_pre.xml	Edgar Link	unprocessable
actg-2022331xex311.htm	Edgar Link	pending
actg-2022331xex312.htm	Edgar Link	pending
actg-2022331xex321.htm	Edgar Link	pending
actg-2022331xex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACTG
ACACIA RESEARCH CORP Stock $actg

2022 Q1 Form 10-Q Financial Statement

#000093454922000027 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG ACACIA RESEARCH CORP Stock $actg

2022 Q1 Form 10-Q Financial Statement

#000093454922000027 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG
ACACIA RESEARCH CORP Stock $actg